CTOs on the Move

Unum Therapeutics

www.unumrx.com

 
Unum is a Cambridge, MA-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. Unum has built an antibody-coupled T-cell receptor (ACTR) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic T-lymphocytes (CTLs) to kill tumor cells. In contrast to other approaches that hit a single target and treat a narrow set of tumors, Unum’s approach is not restricted by antigens and may have applications for treating many types of cancers.   Our lead program based on ACTR technology is expected to enter Phase I clinical testing soon to assess safety and efficacy in certain forms ...
  • Number of Employees: 0-25
  • Annual Revenue: $50-100 Million
  • www.unumrx.com
  • One Broadway 4th Floor
    Cambridge, MA USA 02142
  • Phone: 617.843.5032

Executives

Name Title Contact Details

Funding

Unum Therapeutics raised $65M on 06/11/2015
Unum Therapeutics raised $104.4M on 07/06/2020

Similar Companies

Hospice Provider Group Inc

Hospice Provider Group Inc is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oncopeptides AB

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers.

BIOSAFE Inc

BIOSAFE Inc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Tolerance Network

Immune Tolerance Network is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wraser Pharmaceuticals

Wraser Pharmaceuticals is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.